Revolutionising IVF through artificial intelligence
Renowned expert in AI enhanced healthcare, South Australian Dr Michelle Perugini has developed new technology that uses artificial intelligence to improve the success rate of IVF.
There are around 300 million people globally who are unable to conceive naturally, according to Dr Michelle Perugini. Many turn to IVF to start their families. But IVF isn’t guaranteed to succeed. And the process can be challenging. So, Michelle has developed new technology that uses artificial intelligence to improve the success rate of IVF.
Michelle is an entrepreneur, academic and internationally renowned expert in health, medical research, advanced analytics and AI. In 2017, she co-founded Presagen, an AI healthcare company focussed on women’s health. It’s part of the growing ‘femtech’ (female technology) industry catering to the underserved area of women’s health.
"This is cutting-edge new technology that is world first, that is impacting the lives of patients across the globe. And this is from Australia."
IVF usually relies on subjective visual decision-making by specialists. This means success rates can vary between clinics and the process is subject to human error. Michelle’s AI-based platform, called ‘Life Whisperer’, helps to take the guesswork out of the process. Harnessing machine learning, it has the power to revolutionise IVF and to change how AI is used in healthcare.
This innovative technology now has initial users in multiple countries and approvals to sell in two-thirds of the world’s markets. Michelle believes its potential is limitless.
Watch the video above to find out how Dr Michelle Perugini’s transformative technology platform uses artificial intelligence to increase IVF success rates around the world.
